1. Home
  2. KNF vs GRFS Comparison

KNF vs GRFS Comparison

Compare KNF & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNF
  • GRFS
  • Stock Information
  • Founded
  • KNF 1917
  • GRFS 1940
  • Country
  • KNF United States
  • GRFS Spain
  • Employees
  • KNF N/A
  • GRFS N/A
  • Industry
  • KNF
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • KNF
  • GRFS Health Care
  • Exchange
  • KNF Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • KNF 5.3B
  • GRFS 6.2B
  • IPO Year
  • KNF N/A
  • GRFS 2006
  • Fundamental
  • Price
  • KNF $82.57
  • GRFS $10.70
  • Analyst Decision
  • KNF Strong Buy
  • GRFS Hold
  • Analyst Count
  • KNF 6
  • GRFS 1
  • Target Price
  • KNF $114.17
  • GRFS $10.30
  • AVG Volume (30 Days)
  • KNF 643.2K
  • GRFS 1.3M
  • Earning Date
  • KNF 08-05-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • KNF N/A
  • GRFS N/A
  • EPS Growth
  • KNF 1.95
  • GRFS N/A
  • EPS
  • KNF 3.18
  • GRFS 0.53
  • Revenue
  • KNF $2,922,886,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • KNF $14.69
  • GRFS $5.40
  • Revenue Next Year
  • KNF $7.28
  • GRFS $6.74
  • P/E Ratio
  • KNF $25.93
  • GRFS $26.99
  • Revenue Growth
  • KNF 2.48
  • GRFS 10.76
  • 52 Week Low
  • KNF $67.22
  • GRFS $6.19
  • 52 Week High
  • KNF $108.83
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • KNF 51.86
  • GRFS 72.04
  • Support Level
  • KNF $80.36
  • GRFS $9.53
  • Resistance Level
  • KNF $82.80
  • GRFS $11.14
  • Average True Range (ATR)
  • KNF 1.92
  • GRFS 0.30
  • MACD
  • KNF 0.68
  • GRFS 0.06
  • Stochastic Oscillator
  • KNF 93.40
  • GRFS 72.67

About KNF Knife Riv Holding Co.

Knife River Holding Co is an aggregates-led construction materials and contracting services provider. Its segments include Pacific, Northwest, Mountain, North Central, South, and Energy Services. Each geographic segment offers a vertically integrated suite of products and services, including aggregates, ready-mix concrete, asphalt, and contracting services, while the Energy Services segment, which has locations throughout the company's geographic footprint, produces and supplies liquid asphalt and related services, for use in asphalt road construction, and is a supplier to some of the other segments.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: